Effects of gestational hypertension and pre-eclampsia in mRNA expression of fibrinolysis genes in primary cultured human umbilical vein endothelial cells.

作者: Irais Poblete-Naredo , Yury Rodríguez-Yáñez , Rogelio O. Corona-Núñez , Stuart González-Monroy , Juan E. Salinas

DOI: 10.1016/J.THROMRES.2018.05.017

关键词:

摘要: Hypertension disorders (HD) and pre-eclampsia (PRE) are leading causes of maternal deaths worldwide. PRE is associated with vascular endothelial dysfunction deregulation the fibrinolysis pathway genes. Fibrinolysis fibrin clot hydrolysis process catalyzed by plasmin, a proteolytic enzyme formed from plasminogen. Plasminogen cleaved tissue-type (tPA) urokinase-type (uPA) activators inhibited plasminogen activator inhibitors type-1 (PAI-1) type-2 (PAI-2). The whole maintains blood hemostasis. This study aims to assess PAI-1, PAI-2, tPA uPA mRNA expression in primary cultured human umbilical vein cells (HUVEC) isolated healthy, HD women. Results show that PAI-1 PAI-2 decreased HD-HUVEC, whereas PRE-HUVEC cultures compared control ones. Notably, ratio between pro- anti-fibrinolytic actors remained unchanged among studied groups. It seems newborn's hemostasis maintained balanced probably compensatory mechanism involves changes gene profile. real impact these unknown, however, it suggested could be an increased predisposition disease development progeny.

参考文章(28)
Steven A. Friedman, Eyal Schiff, Jef J. Emeis, Gustaaf A. Dekker, Baha M. Sibai, Biochemical corroboration of endothelial involvement in severe preeclampsia American Journal of Obstetrics and Gynecology. ,vol. 172, pp. 202- 203 ,(1995) , 10.1016/0002-9378(95)90113-2
M.B. Pinheiro, K.B. Gomes, L.M.S. Dusse, Fibrinolytic system in preeclampsia. Clinica Chimica Acta. ,vol. 416, pp. 67- 71 ,(2013) , 10.1016/J.CCA.2012.10.060
W. Heyl, S. Handt, F. Reister, J. Gehlen, C. Mittermayer, W. Rath, Increased t-PA and PAI-1 expression of cultured endothelial cells after stimulation with sera from women with preeclampsia Fibrinolysis and Proteolysis. ,vol. 11, pp. 273- 278 ,(1997) , 10.1016/S0268-9499(97)80112-9
A.L. Tranquilli, G. Dekker, L. Magee, J. Roberts, B.M. Sibai, W. Steyn, G.G. Zeeman, M.A. Brown, The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. ,vol. 4, pp. 97- 104 ,(2014) , 10.1016/J.PREGHY.2014.02.001
Eva Maria Roes, C.G.Fred Sweep, Chris M. Thomas, Petra L. Zusterzeel, Anneke Geurts-Moespot, Wilbert H. Peters, Eric A. Steegers, Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia. American Journal of Obstetrics and Gynecology. ,vol. 187, pp. 1019- 1025 ,(2002) , 10.1067/MOB.2002.126280
Dennis A. Davey, Ian MacGillivray, The classification and definition of the hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology. ,vol. 158, pp. 892- 898 ,(1988) , 10.1016/0002-9378(88)90090-7
Yuditiya Purwosunu, Akihiko Sekizawa, Keiko Koide, Antonio Farina, Noroyono Wibowo, Gulardi Hanifa Wiknjosastro, Shiho Okazaki, Hiroshi Chiba, Takashi Okai, Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clinical Chemistry. ,vol. 53, pp. 399- 404 ,(2007) , 10.1373/CLINCHEM.2006.081372
Vincenzo Zanardo, Valentina Savio, Gavasso Sabrina, Malida Franzoi, Patrizia Zerbinati, Mariangela Fadin, Giulio Tognin, Daniela Tormene, Antonio Pagnan, Paolo Simioni, The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns. Blood Coagulation & Fibrinolysis. ,vol. 16, pp. 177- 181 ,(2005) , 10.1097/01.MBC.0000164425.67674.90